These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4768915)

  • 21. [Attempt to establish evaluation standards for a bivalent vaccine against leptospirosis of farm animals, using LMAR (leptospirosis micro-agglutination reaction].
    Stoianova L; Todorova R
    Vet Med Nauki; 1974; 11(7):39-45. PubMed ID: 4475510
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification and characterization of OmpA-like proteins as novel vaccine candidates for Leptospirosis.
    Yan W; Faisal SM; McDonough SP; Chang CF; Pan MJ; Akey B; Chang YF
    Vaccine; 2010 Mar; 28(11):2277-83. PubMed ID: 20064477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunogenicity and protective capacity of leptospiral whole-cell monovalent serogroup Ballum vaccines in hamsters].
    González A; Rodríguez Y; Batista N; Valdés Y; Núñez JF; Mirabal M; González M
    Rev Argent Microbiol; 2005; 37(4):169-75. PubMed ID: 16502635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates.
    Chang YF; Chen CS; Palaniappan RU; He H; McDonough SP; Barr SC; Yan W; Faisal SM; Pan MJ; Chang CF
    Vaccine; 2007 Nov; 25(48):8190-7. PubMed ID: 17936448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Lsa46 and Lsa77 Leptospiral Proteins for Their Immunoprotective Activities in Hamster Model of Leptospirosis.
    Teixeira AF; Fernandes LGV; Souza Filho A; Souza GO; Vasconcellos SA; Heinemann MB; Nascimento ALTO
    Biomed Res Int; 2018; 2018():1813745. PubMed ID: 29984227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Leptospira in vitro potency assays: EU/industry experience and perspectives.
    Klaasen HL; van der Veen M; Molkenboer MJ; Bruderer U
    Biologicals; 2013 Sep; 41(5):315-22. PubMed ID: 23867758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opportunities and strategies to further reduce animal use for Leptospira vaccine potency testing.
    Walker A; Srinivas GB
    Biologicals; 2013 Sep; 41(5):332-7. PubMed ID: 23891496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of animal-passage and in vitro cultivation in homologous antiserum on leptospiral antigenicity.
    Stalheim OH
    Arch Exp Veterinarmed; 1974 Mar; 28(3):243-7. PubMed ID: 4846590
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of two different potency tests for leptospirosis vaccine vax-SPIRAL.
    Núñez JF; Fajardo EM; Pérez E; Ontivero I; Silva D; Muñoz P
    Rev Cubana Med Trop; 2005; 57(1):67-8. PubMed ID: 17966487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International regulatory requirements for Leptospira vaccine potency testing. Roundtable: current requirements and opportunity for harmonization.
    Draayer HA; Bruckner L; Peña-Moctezuma Ade L; Srinivas G
    Biologicals; 2013 Sep; 41(5):305-7. PubMed ID: 23890730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterologous protection elicited by a live, attenuated, Leptospira vaccine.
    Murray GL; Simawaranon T; Kaewraemruaen C; Adler B; Sermswan RW
    Vet Microbiol; 2018 Sep; 223():47-50. PubMed ID: 30173751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental immunization of hamsters with an EDTA extract of Leptospira interrogans, serovar icterohaemorrhagiae.
    de Queiroz-Leite LT; Resende M; Ramos-Vieira M das N; Cota-Koury M
    Rev Latinoam Microbiol; 1996; 38(1):39-43. PubMed ID: 8783904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of 238 antigens of Leptospira borgpetersenii serovar Hardjo for protection against kidney colonisation.
    Murray GL; Lo M; Bulach DM; Srikram A; Seemann T; Quinsey NS; Sermswan RW; Allen A; Adler B
    Vaccine; 2013 Jan; 31(3):495-9. PubMed ID: 23176980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and identification of leptospira hardjo from cattle in Argentina.
    Myers DM; Jelambi F
    Trop Geogr Med; 1975 Mar; 27(1):63-70. PubMed ID: 49113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An in vitro growth inhibition test for measuring the potency of Leptospira spp. Sejroe group vaccine in buffaloes.
    de Nardi G; Genovez ME; Ribeiro MG; Castro V; Jorge AM
    Biologicals; 2010 Jul; 38(4):474-8. PubMed ID: 20332068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion of the in vitro assay for Leptospira potency testing to other serovars: case study with Leptospira Hardjo.
    Alt DP; Wilson-Welder J
    Biologicals; 2013 Sep; 41(5):323-4. PubMed ID: 23838569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leptospirosis vaccines: past, present, and future.
    Koizumi N; Watanabe H
    J Postgrad Med; 2005; 51(3):210-4. PubMed ID: 16333195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Avirulent leptospira pomona vaccine: stability of the noninfectious character in vitro and in vivo.
    Stalheim OH
    Proc Annu Meet U S Anim Health Assoc; 1968; 72():182-91. PubMed ID: 5257460
    [No Abstract]   [Full Text] [Related]  

  • 39. LemA and Erp Y-like recombinant proteins from Leptospira interrogans protect hamsters from challenge using AddaVax™ as adjuvant.
    Oliveira TL; Schuch RA; Inda GR; Roloff BC; Neto ACPS; Amaral M; Dellagostin OA; Hartwig DD
    Vaccine; 2018 May; 36(19):2574-2580. PubMed ID: 29625765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis.
    Conrad NL; Cruz McBride FW; Souza JD; Silveira MM; Félix S; Mendonça KS; Santos CS; Athanazio DA; Medeiros MA; Reis MG; Dellagostin OA; McBride AJ
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005441. PubMed ID: 28301479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.